Karen L. Parkhill - 02 Aug 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role: EVP & Chief Financial Officer
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol: MDT
Transactions as of: 02 Aug 2021
Net transactions value: -$898,029
Form type: 4
Filing time: 04 Aug 2021, 18:23:09 UTC
Previous filing: 28 Jun 2021
Next filing: 14 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Tax liability	$898,029	-6,839	-8%	$131.31	78,671	02 Aug 2021	Direct	F1, F2
transaction	MDT	Ordinary Shares	Award	$0	+7,162	+9.1%	$0.000000	85,833	02 Aug 2021	Direct	F3
holding	MDT	Ordinary Shares						843	02 Aug 2021	By Child #1
holding	MDT	Ordinary Shares						843	02 Aug 2021	By Child #2
holding	MDT	Ordinary Shares						843	02 Aug 2021	By Child #3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+61,187		$0.000000	61,187	02 Aug 2021	Ordinary Shares	61,187	$131.26	Direct	F4
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+1,085		$0.000000	1,085	02 Aug 2021	Ordinary Shares	1,085	$131.26	Direct	F4
transaction	MDT	Performance Share Units	Award	$0	+17,904		$0.000000	17,904	02 Aug 2021	Performance Share Units	17,904		Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment.
F2	This balance increased by 198 shares due to exempt transactions such as dividend reinvestment.
F3	The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F4	These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F5	Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,904 shares will be issued. The actual number of shares to be issued could range from a low of 3,581 at minimum performance to a high of 35,808 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7	Vests on August 2, 2024.